Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03782116 · ClinicalTrials.gov registry record · NA

Stress Incontinence Trial With Elitone Device

A NA study of Stress Urinary Incontinence, sponsored by Elidah.

Completed
Registry status
NA
Development phase
87
Enrollment target
1
Study location

NCT03782116 is a NA study of Stress Urinary Incontinence that has completed, run by Elidah. The registered enrollment target is 87 participants, below the 160-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (46% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03782116, a NA study of Stress Urinary Incontinence, has completed, sponsored by Elidah.

COMPLETED
Registry status
NA
Development phase
87 participants
Enrollment target
1
Study location

Study Summary

This is a randomized controlled study in which subjects are assigned to either a treatment group or a control (sham) group. Pre- and post-study outcome measures evaluate the change in incontinence episodes on women with mild-moderate stress urinary incontinence.

Interventions

  • DEVICE Transcutaneous electrical stimulation (Elitone)

Study Locations (1)

Connecticut

  • Nationwide At-Home study - Monroe

Trial Details

FieldValue
Enrollment Target 87 participants
Start Date 2018-09-01
Est. Completion 2019-03-31
Phase NA

Sponsor

Elidah

4 total trials

What the Registry Record Tells You About NCT03782116

The ClinicalTrials.gov registry entry for NCT03782116 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 87 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 160-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (46% lower). The listed sponsor is Elidah, which has 4 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stress Urinary Incontinence appearing as the primary indexed condition, and to 1 intervention - of which Transcutaneous electrical stimulation (Elitone) is the first listed.

NCT03782116 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT03782116 about?

NCT03782116 is a clinical study titled "Stress Incontinence Trial With Elitone Device". This is a randomized controlled study in which subjects are assigned to either a treatment group or a control (sham) group. Pre- and post-study outcome measures evaluate the change in incontinence episodes on women with mild-moderate stress urinary incontinence.

What is the current status of trial NCT03782116?

This trial is currently completed. It is a NA study. The enrollment target is 87 participants. The study started on 2018-09-01. Estimated completion is 2019-03-31.

What conditions does trial NCT03782116 study?

This clinical trial studies the following conditions: Stress Urinary Incontinence.

What interventions are being tested in trial NCT03782116?

The interventions under investigation include: Transcutaneous electrical stimulation (Elitone) (DEVICE).

Who is sponsoring clinical trial NCT03782116?

This trial is sponsored by Elidah, which has 4 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03782116 being conducted?

This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress Urinary Incontinence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.